Management of hypertension using Homoeopathic medicines
Not Applicable
Completed
- Conditions
- Health Condition 1: I10- Essential (primary) hypertension
- Registration Number
- CTRI/2020/01/023085
- Lead Sponsor
- Khan Sheeba Saleem
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Males and Non lactating and non pregnant females not suffering from any other systemic disorder besides stage 1 of primary essential hypertension
Exclusion Criteria
Lactating and pregnant females, age beyond 18-65years, cases of hypertension with uncontrolled systemic illness and stage 3 and 4 of hypertension according to 7th report of JNC for prevention and detection of hypertension
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie homeopathic medicine effects on renin-angiotensin system in essential hypertension?
How does Boenninghausens repertory-guided homeopathy compare to ACE inhibitors in primary hypertension management?
Are there biomarkers predicting response to homeopathic interventions in CTRI/2020/01/023085 trial participants?
What adverse events were documented in homeopathic hypertension trials using Boger's repertory methodology?
What combination therapies synergize with homeopathic approaches for blood pressure control in essential hypertension?